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A B S T R A C T
Dermal fibroblasts were donated by a 43 year old male patient with clinically diagnosed familial amyotrophic lateral sclerosis (ALS), carrying the SOD1 E101G mutation. The induced pluripotent stem cell (iPSC) line UOWi007-A was generated using repeated mRNA transfections for pluripotency transcription factors Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog. The iPSCs carried the SOD1 E101G genotype and had a normal karyotype, expressed expected pluripotency markers and were capable of in vitro differentiation into endodermal, mesodermal and ectodermal lineages. This iPSC line may be useful for investigating familial ALS resulting from a SOD1 E101G mutation.
Resource table
Unique stem cell line identifier 
Resource utility
This iPSC line can be used to investigate familial ALS resulting from a SOD1 E101G mutation. This resource is available under request owing to the Materials Transfer Agreement in place.
Resource details
Dermal fibroblasts were obtained from a 43 year old male patient by Macquarie University, Australia. The patient was clinically diagnosed with familial amyotrophic lateral sclerosis (ALS), heterozygous for the SOD1 E101G mutation (also termed SOD1 E100G due to N-terminal methionine cleavage). The SOD1 gene encodes the cytosolic antioxidant enzyme, copper-zinc superoxide dismutase (SOD1). Mutant SOD1 E101G retains the wild-type-like dismutase activity of the enzyme with pathology hypothesized to be due to misfolding and subsequent aggregation of mutant SOD1 (Valentine et al., 2005; Farrawell et Reprogramming was performed using repeated mRNA transfections for pluripotency transcription factors Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog. The first iPSC colonies appeared on day 14 and were isolated on day 17 for expansion and characterisation, with clone 2 (UOWi007-A) selected following confirmation of pluripotency. The UOWi007-A line was authenticated against its parental fibroblast line via short tandem repeat (STR) profiling, with sequencing confirming the presence of the SOD1 E101G mutation (Fig. 1A) . The UOWi007-A colonies had a normal karyotype ( Fig. 1B) , with no abnormalities detected in 15 cells at 400 bands per haploid set and had characteristic stem cell morphology (Fig. 1C ). Immunocytochemical analysis confirmed expression of pluripotency markers Oct4, SSEA-4 and TRA-1-60 ( Fig. 1D ). Transcription of endogenous pluripotency genes NANOG and POU5F1 (Oct4) by quantitative RT-PCR (RT-qPCR) showed a 360 and 2700 fold increase, respectively, in UOWi007-A in comparison to R. Balez, et al. Stem Cell Research 42 (2020) 101701 parental fibroblasts (Fig. 1E ) and similar expression levels compared to another iPSC line UOWi002-A (Muñoz et al., 2018) . In addition, pluripotency was assessed using the hPSC Scorecard assay, with an upregulation of mesodermal, endodermal and ectodermal specific genes and a downregulation of genes associated with pluripotency ( Fig. 1F ).
Materials and methods

Reprogramming of human dermal fibroblasts
Dermal fibroblasts were cultured in Dulbecco's Modified Eagle Medium F12 (DMEM/F12, Thermo Fisher Scientific) with 1x Non-Essential Amino Acids (Thermo Fisher Scientific) and 10% foetal bovine serum (Interpath) at 37°C and 5% CO 2 . Fibroblasts were reprogrammed using StemMACS mRNA Reprogramming Kit (Myltenyi Biotec #130-104-460) following the manufacture's protocol. Spontaneous iPSC colonies were isolated and expanded into individual iPSC lines (clones). Established iPSC clones were maintained in TeSR-E8™ (Stemcell Technologies) on Matrigel-coated plates (Corning) at 37°C and 5% CO 2 and passaged (1:5) using dispase (Stemcell Technologies) (See Table 1 ). The study was approved by the University of Wollongong Human Ethics Committee (HE 13/272).
Sequencing
Genomic DNA was extracted using the ISOLATE II Genomic DNA Kit (Bioline), with DNA amplified by PCR using MyTaq HS DNA Polymerase (Bioline) with the SOD1 primers (Table 2) . Sequencing reactions were performed using the ABI BigDye Terminator v3.1 Ready Reaction Mix and separated using the 3500xL Genetic Analyzer (Applied Biosystems). BioEdit (Ibis Therapeutics) was used to analyse the sequences.
Karyotyping
Karyotyping was performed at Sullivan Nicolaides Pathology Pty Ltd (Brisbane, Australia), on iPSCs at passage 24, with 15 metaphase spreads counted at 400 bphs.
Immunofluorescence staining
The iPSCs were fixed in 4% paraformaldehyde for 10 min, permeabilised with 0.05% Triton-X for 7 min (SSEA-4) or 15 min (Oct4) and blocked in 10% goat serum for 1 h at 22°C. Primary antibodies Oct4 and SSEA-4 (Table 2) were incubated overnight at 4°C, followed by secondary antibody (Table 2) for 1 h at 22°C. Cultures were counter stained with Reddot2 (1:200, Biotium) for 10 min at 22°C. For TRA-1-60 staining, cultures were incubated with TRA-1-60 live stain following manufacture's protocol. Immunocytochemical preparations were imaged with a Leica DMI6000B confocal microscope and acquired using LAS AF 2.6 software (Leica Microsystems).
Quantitative polymerase chain reaction (qPCR)
Fibroblast and iPSC RNA was extracted using Tri-Reagent (MRC Gene) as per manufacture's protocol. Genomic DNA was removed using the Turbo DNAse kit (Thermo Fisher Scientific) and RNA purity determined using a Nanodrop 2000C. Tetro Reverse Transcriptase kit was used for cDNA synthesis (Bioline). The expression of POU5F1 and NANOG was assessed via qPCR using SensiFast SYBR (Bioline) on the R. Balez, et al. Stem Cell Research 42 (2020) 101701 Corbett RotorGene 3000 (Thermo Fisher Scientific) and normalised to the expression of housekeeper genes HPRT1 and GAPDH. Difference in expression was calculated via the ΔΔct method.
Scorecard
Mesodermal and endodermal differentiation was induced using the STEMdiff Mesoderm Induction Medium (Stemcell Technologies) and STEMdiff Definitive Endoderm Kit (Stemcell Technologies), respectively, following the manufacture's protocols. Induction of ectodermal differentiation was achieved using Neural Induction medium (DMEM/ F12, 1% N2, 0.4% B27, 1% MEM Non-essential amino acids, 1% GlutaMAX) supplemented with 1 μM LDN193189 (Focus Bioscience) for 2 days. The iPSC colonies were detached with dispase (Thermo Fisher Scientific) to form embryoid bodies and cultured in Neural Induction medium supplemented with 3 μM CHIR99021 (Focus Bioscience) and 2 μM SB431542 (Focus Bioscience) for 7 days. From each culture, cDNA was mixed at a ratio of 1:1:1, with 1 μg analysed with the TaqMan hPSC Scorecard (Thermo Fisher Scientific) following the manufacturer's protocol.
STR analysis
STR analysis of 18 locations was performed at Garvan Molecular Genetics Institute (Darlinghurst, Australia).
Declaration of Competing Interest
None.
